Low rate of conversion to positive tuberculosis status among patients with psoriasis on biologic therapies: A retrospective study from a US academic medical center

J Am Acad Dermatol. 2021 Mar;84(3):830-833. doi: 10.1016/j.jaad.2020.09.075. Epub 2020 Oct 1.

Authors

Vijaya T Daniel¹, Kaitlin C Blankenship¹, Robert F Daly¹, Elizabeth Tkachenko², Peyton C Morss-Walton¹, Nikki A Levin³

Affiliations

¹ Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.
² Brigham and Women's Hospital, Department of Internal Medicine, Boston, Massachusetts.
³ Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts. Electronic address: Nikki.levin@umassmemorial.org.

PMID: 33010315
DOI: 10.1016/j.jaad.2020.09.075

No abstract available

Publication types

Letter

MeSH terms

Academic Medical Centers / statistics & numerical data
Adolescent
Adult
Aged
Aged, 80 and over
Biological Products / adverse effects*
Child
Female
Humans
Interferon-gamma Release Tests / statistics & numerical data
Latent Tuberculosis / blood
Latent Tuberculosis / diagnosis
Latent Tuberculosis / epidemiology*
Latent Tuberculosis / immunology
Male
Middle Aged
Prevalence
Psoriasis / drug therapy*
Psoriasis / immunology
Retrospective Studies
Seroconversion / drug effects
United States / epidemiology
Young Adult

Substances

Biological Products